Wilson Sonsini is pleased to support LaunchBio’s “Invest in Cures.” This event explores the rising trend of impact investing through disease foundations and innovative approaches to addressing rare disease challenges. Foundation leaders, advocates, and entrepreneurs will share how a targeted venture philanthropy approach is accelerating the commercialization of life-saving therapies. Discover how collaborative efforts are lowering the barriers of diagnosis and treatment of rare disease. This forum examines the foundation venture funds and their investment philosophies, highlights successful collaborations with start-ups as well as disease advocacy groups, and offers matchmaking opportunities for venture funds and start-ups that align with their investment profile.

Deborah Smith PhD, JD, will be moderating the opening session, “The Rise of Impact Investing — How Disease Foundations are Translating Science Into Cures.”